These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 5106293

  • 1. Experimental autoallergic encephalomyelitis and cellular hypersensitivity in vitro.
    Ellison GW, Waksman BH, Ruddle NH.
    Neurology; 1971 Aug; 21(8):778-82. PubMed ID: 5106293
    [No Abstract] [Full Text] [Related]

  • 2. Experimental autoallergic encephalomyelitis and cell-mediated hypersensitivity in vitro.
    Ellison GW, Waksman BH, Ruddle NH.
    Neurology; 1970 Apr; 20(4):389-90. PubMed ID: 5535014
    [No Abstract] [Full Text] [Related]

  • 3. The application of the irradiated hamster test to the study of experimental allergic encephalomyelitis.
    Kornblum J.
    J Immunol; 1968 Oct; 101(4):702-10. PubMed ID: 5681650
    [No Abstract] [Full Text] [Related]

  • 4. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis.
    Falk GA, Kies MW, Alvord EC.
    J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475
    [No Abstract] [Full Text] [Related]

  • 5. Temporal dissociation of experimental allergic encephalomyelitis transfer activity and gamma globulin staining of lymphoid cells from sensitized Lewis rats.
    Richardson WP, Paterson PY.
    J Immunol; 1970 Dec; 105(6):1563-4. PubMed ID: 4098508
    [No Abstract] [Full Text] [Related]

  • 6. Reduction of allergic encephalomyelitis incubation period to five days.
    Levine S, Sowinski R.
    Am J Pathol; 1969 Jul; 56(1):97-109. PubMed ID: 4978310
    [No Abstract] [Full Text] [Related]

  • 7. Experimental allergic encephalomyelitis: demyelinating activity of serum and sensitized lymph node cells on cultured nerve tissues.
    Bornstein MB, Iwanami H.
    J Neuropathol Exp Neurol; 1971 Apr; 30(2):240-8. PubMed ID: 5147780
    [No Abstract] [Full Text] [Related]

  • 8. In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis.
    Webb C, Teitelbaum D, Arnon R, Sela M.
    Eur J Immunol; 1973 May; 3(5):279-86. PubMed ID: 4128128
    [No Abstract] [Full Text] [Related]

  • 9. Transformation of lymphocytes from monkeys with experimental allergic encephalomyelitis.
    Chaparas SD, Clark RG, Kies MW, Hedrick SR.
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):637-52. PubMed ID: 5002788
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.
    Sun JB, Rask C, Olsson T, Holmgren J, Czerkinsky C.
    Proc Natl Acad Sci U S A; 1996 Jul 09; 93(14):7196-201. PubMed ID: 8692968
    [Abstract] [Full Text] [Related]

  • 11. Activation of effector cells in experimental allergic encephalomyelitis by interleukin 2 (IL-2).
    Ortiz-Ortiz L, Weigle WO.
    J Immunol; 1982 Apr 09; 128(4):1545-50. PubMed ID: 6174605
    [No Abstract] [Full Text] [Related]

  • 12. Transfer of experimental allergic encephalomyelitis in Lewis rats using supernates of incubated sensitized lymph node cells.
    Whitacre CC, Paterson PY.
    J Exp Med; 1977 May 01; 145(5):1405-10. PubMed ID: 300784
    [Abstract] [Full Text] [Related]

  • 13. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ, Hur M, Kim YL, Lee GH, Kim J, Kim I, Lee M, Han HK, Kim MS, Hwang S, Kim S, Woo AM, Yoon Y, Park HJ, Won J.
    J Pharmacol Exp Ther; 2009 Dec 01; 331(3):1005-13. PubMed ID: 19741152
    [Abstract] [Full Text] [Related]

  • 14. [Electrophoretic mobility of lymph node cells in experimental allergic encephalomyelitis].
    Jenssen HL, Köhler H, Gundlach HJ, Günther J, Eckert R.
    Acta Biol Med Ger; 1974 Dec 01; 32(1):113-9. PubMed ID: 4547024
    [No Abstract] [Full Text] [Related]

  • 15. Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis.
    Mor F, Cohen IR.
    J Clin Invest; 1993 Nov 01; 92(5):2199-206. PubMed ID: 7693759
    [Abstract] [Full Text] [Related]

  • 16. Passive transfer of experimental allergic encephalomyelitis: mechanisms of suppression.
    Falk GA, Kies MW, Alvord EC.
    J Immunol; 1969 Dec 01; 103(6):1248-53. PubMed ID: 5361563
    [No Abstract] [Full Text] [Related]

  • 17. Allergic encephalomyelitis: immunologically specific inhibition of cellular passive transfer by encephalitogenic basic proteins.
    Levine S, Hoenig EM, Kies MW.
    Clin Exp Immunol; 1970 Apr 01; 6(4):503-17. PubMed ID: 4991116
    [Abstract] [Full Text] [Related]

  • 18. [On the pathogenesis of organic and systemic disorders in trichinosis. II. Experimental trichinous allergic encephalomyelitis].
    Ozeretskovskaia NN, Vikhert AM, Frol'tsova AE, Konovalova LM.
    Med Parazitol (Mosk); 1966 Apr 01; 35(4):395-402. PubMed ID: 5993825
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of self tolerance in experimental allergic encephalomyelitis. I. Differences between lymph node and spleen suppressor cells.
    Welch AM, Swierkosz JE, Swanborg RH.
    J Immunol; 1978 Nov 01; 121(5):1701-5. PubMed ID: 309479
    [No Abstract] [Full Text] [Related]

  • 20. Chronic-relapsing experimental allergic encephalomyelitis in Lewis rats: correlation between clinical state and antimyelin basic protein reactivity in draining lymph node cells.
    Chabannes D, Borel JF.
    Transplant Proc; 1990 Dec 01; 22(6):2591-3. PubMed ID: 1702242
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.